Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8568 ...

Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive ... This alarming statistic underscores the need for effective treatment options, ...

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

Here is a look at the NEET UG 2025 syllabus and answers to frequently asked questions regarding the Biology subject.

The Truvaga Plus claims to relieve stress, improve sleep, and clear brain fog — but does it really deliver? We tested it out.

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have developed a new portable plasma device ...

A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy ...

Pulmonary rehabilitation significantly improves physical capacity, lung function, and quality of life in long COVID patients, with the greatest benefits seen in 4-8 week programs combining breathing ...

A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes ...